Issue 3/2023
Content (22 Articles)
Intratumoral pro-oxidants promote cancer immunotherapy by recruiting and reprogramming neutrophils to eliminate tumors
Stephen John Ralph, Maxwell J. Reynolds
Invariant NKT cells metabolically adapt to the acute myeloid leukaemia environment
Victoria Stavrou, Livingstone Fultang, Sarah Booth, Daniele De Simone, Arekdiusz Bartnik, Ugo Scarpa, Luciana Gneo, Silvia Panetti, Sandeep Potluri, Meaad Almowaled, Jonathan Barlow, Andris Jankevics, Gavin Lloyd, Andrew Southam, David A. Priestman, Paul Cheng, Warwick Dunn, Frances Platt, Hitoshi Endou, Charles Craddock, Karen Keeshan, Francis Mussai, Carmela De Santo
Protein Expression of immune checkpoints STING and MHCII in small cell lung cancer
David Dora, Christopher Rivard, Hui Yu, Shivaun Lueke Pickard, Viktoria Laszlo, Tunde Harko, Zsolt Megyesfalvi, Csongor Gerdan, Elek Dinya, Konrad Hoetzenecker, Fred R. Hirsch, Zoltan Lohinai, Balazs Dome
Interplay between plasmacytoid dendritic cells and tumor-specific T cells in peripheral blood influences long-term survival in non-small cell lung carcinoma
Caroline Laheurte, Evan Seffar, Eléonore Gravelin, Julie Lecuelle, Adeline Renaudin, Laura Boullerot, Marine Malfroy, Amélie Marguier, Benoit Lecoester, Béatrice Gaugler, Philippe Saas, Caroline Truntzer, Francois Ghiringhelli, Olivier Adotevi
Risk of pneumonitis in non-small cell lung cancer patients with preexisting interstitial lung diseases treated with immune checkpoint inhibitors: a nationwide retrospective cohort study
Kenji Sawa, Izumi Sato, Masato Takeuchi, Koji Kawakami
Machine learning algorithm-generated and multi-center validated melanoma prognostic signature with inspiration for treatment management
Zaoqu Liu, Hui Xu, Siyuan Weng, Chunguang Guo, Qin Dang, Yuyuan Zhang, Yuqing Ren, Long Liu, Libo Wang, Xiaoyong Ge, Zhe Xing, Jian Zhang, Peng Luo, Xinwei Han
Costimulatory molecule expression profile as a biomarker to predict prognosis and chemotherapy response for patients with small cell lung cancer
Peng Wu, Zhihui Zhang, Zhaoyang Yang, Chaoqi Zhang, Yuejun Luo, Guochao Zhang, Lide Wang, Qi Xue, Nan Sun, Jie He
PD-1+ mast cell enhanced by PD-1 blocking therapy associated with resistance to immunotherapy
Jun Li, Gang Peng, Kuikui Zhu, Xiaohua Jie, Yingzhuo Xu, Xinrui Rao, Yunhong Xu, Yunshang Chen, Biyuan Xing, Gang Wu, Liangliang Shi
Identification of the molecular subtype and prognostic characteristics of pancreatic cancer based on CD8 + T cell-related genes
Dafeng Xu, Yu Wang, Yonghai Chen, Jinfang Zheng
Correction to: Identification of the molecular subtype and prognostic characteristics of pancreatic cancer based on CD8 + T cell-related genes
Dafeng Xu, Yu Wang, Yonghai Chen, Jinfang Zheng
Blockade of IL-1α and IL-1β signaling by the anti-IL1RAP antibody nadunolimab (CAN04) mediates synergistic anti-tumor efficacy with chemotherapy
Camilla Rydberg Millrud, Adnan Deronic, Caitríona Grönberg, Elin Jaensson Gyllenbäck, Karin von Wachenfeldt, Göran Forsberg, David Liberg
Single-cell and spatial transcriptome analyses revealed cell heterogeneity and immune environment alternations in metastatic axillary lymph nodes in breast cancer
Xiaofan Mao, Dan Zhou, Kairong Lin, Beiying Zhang, Juntao Gao, Fei Ling, Lewei Zhu, Sifei Yu, Peixian Chen, Chuling Zhang, Chunguo Zhang, Guolin Ye, Simon Fong, Guoqiang Chen, Wei Luo
Divergent clinical outcomes in a phase 2B trial of the TLPLDC vaccine in preventing melanoma recurrence and the impact of dendritic cell collection methodology: a randomized clinical trial
Alexandra M. Adams, Elizabeth L. Carpenter, Guy T. Clifton, Timothy J. Vreeland, Robert C. Chick, Anne E. O’Shea, Patrick M. McCarthy, Phillip M. Kemp Bohan, Annelies T. Hickerson, Franklin A. Valdera, Ankur Tiwari, Diane F. Hale, John R. Hyngstrom, Adam C. Berger, James W. Jakub, Jeffrey J. Sussman, Montaser F. Shaheen, Xianzhong Yu, Thomas E. Wagner, Mark B. Faries, George E. Peoples
Compromised activity of natural killer cells in diffuse large b-cell lymphoma is related to lymphoma-induced modification of their surface receptor expression
Tehila Azoulay, Ilana Slouzky, Michal Karmona, Margarita Filatov, Michal Hayun, Yishai Ofran, Galit Sarig, Shimrit Ringelstein-Harlev
PD-L1 antibody enhanced β-glucan antitumor effects via blockade of the immune checkpoints in a melanoma model
Xin Hu, Yifang Shui, Hiroshi Hirano, Kisato Kusano, Wen-Zhi Guo, Masayuki Fujino, Xiao-Kang Li
Detecting monocyte trafficking in an animal model of glioblastoma using R2* and quantitative susceptibility mapping
Runze Yang, A. Max Hamilton, Hongfu Sun, Khalil S. Rawji, Susobhan Sarkar, Reza Mirzaei, G. Bruce Pike, V. Wee. Yong, Jeff F. Dunn
A blood-based immune marker for resistance to pembrolizumab in patients with metastatic urothelial cancer
Maud Rijnders, Debbie G. J. Robbrecht, Astrid A. M. Oostvogels, Mandy van Brakel, Joost L. Boormans, Maureen J. B. Aarts, Hayri E. Balcioglu, Paul Hamberg, Jens Voortman, Hans M. Westgeest, Martijn P. Lolkema, Ronald de Wit, Astrid A. M. van der Veldt, Reno Debets
TCR extracellular domain genetically linked to CD28, 2B4/41BB and DAP10/CD3ζ -engineered NK cells mediates antitumor effects
Shance Li, Chaoting Zhang, Luyan Shen, Xia Teng, Yefei Xiao, Bentong Yu, Zheming Lu
Phase II trial of CV301 vaccine combined with atezolizumab in advanced urothelial carcinoma
Guru P. Sonpavde, Benjamin Louis Maughan, Bradley Alexander McGregor, Xiao X. Wei, Kerry L. Kilbridge, Richard J. Lee, Evan Y. Yu, Michael Thomas Schweizer, Robert B. Montgomery, Heather H. Cheng, Andrew Caleb Hsieh, Rohit Jain, Jaspreet S. Grewal, Cesar Pico-Navarro, Zarina Gafoor, Teresa Perschy, Petros Grivas
The predictive value of inflammatory biomarkers for major pathological response in non-small cell lung cancer patients receiving neoadjuvant chemoimmunotherapy and its association with the immune-related tumor microenvironment: a multi-center study
Chongwu Li, Junqi Wu, Long Jiang, Lei Zhang, Jia Huang, Yu Tian, Yue Zhao, Xiucheng Liu, Lang Xia, Haoran E, Peigen Gao, Likun Hou, Minglei Yang, Minjie Ma, Chunxia Su, Hao Zhang, Hezhong Chen, Yunlang She, Dong Xie, Qingquan Luo, Chang Chen
Correction to: The predictive value of inflammatory biomarkers for major pathological response in non-small cell lung cancer patients receiving neoadjuvant chemoimmunotherapy and its association with the immune-related tumor microenvironment: a multi-center study
Chongwu Li, Junqi Wu, Long Jiang, Lei Zhang, Jia Huang, Yu Tian, Yue Zhao, Xiucheng Liu, Lang Xia, Haoran E, Peigen Gao, Likun Hou, Minglei Yang, Minjie Ma, Chunxia Su, Hao Zhang, Hezhong Chen, Yunlang She, Dong Xie, Qingquan Luo, Chang Chen